Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 7 of about 5 companies and 2 funds for MARK HAHN�
Company Exchange Symbol Last price Quote change Market cap
Cempra Inc NASDAQ CEMP 33.39 -0.41 (-1.21%) 1.46B
Cempra Inc. is a clinical-stage pharmaceutical company focused on developing differentiated antibiotics for the acute care and community settings to meet ...
Executive:
Mark W. Hahn
GlycoMimetics Inc NASDAQ GLYC 7.41 -0.09 (-1.20%) 140.92M
GlycoMimetics, Inc. (GlycoMimetics) is a clinical-stage biotechnology company. The Company focuses on the discovery and development of glycomimetic drugs to ...
Executive:
Mark A. Goldberg MD
Canamex Resources Corp CVE CSQ 0.0500 0.0000 (0.00%) 6.47M
Canamex Resources Corp. is a Canada-based engaged in the process of acquiring mineral resource properties. The company is focused on its flagship gold ...
Executive:
Mark A. Billings
PRECOR INCORPORATED Private
At the core of this company's operations is an innate desire to help customers train their core -- to help its bottom line. Precor makes a variety of ...
Executive:
Mark Gooding
Cempra Holdings, LLC Private
Cempra Holdings isn't afraid of a little staph, or pneumonia for that matter. The company is in the clinical stages of developing antibiotics that treat ...
Executive:
Mark W. Hahn
Mutual Fund Symbol Nav Nav change
Principal Dynamic High Yield Explorer Fund Institutional Class Shares PDYIX 9.65 0.00 (0.00%)
The investment seeks to provide a high level of current income with an emphasis on managing volatility. Under normal circumstances, the fund invests at ...
Executive:
Mark P. Denkinger.
Principal Dynamic High Yield Explorer Fund Class A Shares PDYAX 9.64 0.00 (0.00%)
The investment seeks to provide a high level of current income with an emphasis on managing volatility. Under normal circumstances, the fund invests at ...
Executive:
Mark P. Denkinger.